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Abstract
Objective—To examine the relation between congenital heart defects (CHDs) in offspring and 
estimated maternal occupational exposure to chlorinated solvents, aromatic solvents, and Stoddard 
solvent during the period from one month before conception through the first trimester.
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Methods—The study population included mothers of infants with simple, isolated CHDs and 
mothers of control infants who delivered from 1997 through 2002 and participated in the National 
Birth Defects Prevention Study. Two methods to assess occupational solvent exposure were 
employed: an expert consensus-based approach and a literature-based approach. Multiple logistic 
regression was used to calculate adjusted odds ratios (OR) and 95% confidence intervals (CI) for 
the association between solvent classes and CHDs.
Results—2,951 control mothers and 2,047 CHD case mothers were included. Using the 
consensus-based approach, associations were observed for exposure to any solvent and any 
chlorinated solvent with perimembranous ventricular septal defects (OR 1.6; 95% CI 1.0 to 2.6 
and OR 1.7; 95% CI 1.0 to 2.8 respectively). Using the literature-based approach, associations 
were observed for: any solvent exposure with aortic stenosis (OR 2.1; 95% CI 1.1 to 4.1); and 
Stoddard solvent exposure with d-transposition of the great arteries (OR 2.0; 95% CI 1.0 to 4.2), 
right ventricular outflow tract obstruction defects (OR 1.9; 95% CI 1.1 to 3.3), and pulmonary 
valve stenosis (OR 2.1; 95% CI 1.1 to 3.8).
Conclusions—We found evidence of associations between occupational exposure to solvents 
and several types of CHDs. These results should be interpreted in light of the potential for 
misclassification of exposure.
Keywords
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INTRODUCTION
Organic solvents are carbon-based chemicals that are widely used in occupational settings 
for dissolving or dispersing substances such as fats, oils or waxes, as well as in chemical 
manufacturing. Millions of workers in the United States have the potential for exposure to 
organic solvents used in such products as paints, varnishes, adhesives, and degreasing/
cleaning agents, as well as in the production of dyes, polymers, plastics, textiles, printing 
inks, and agricultural products.1 Most organic solvents are highly volatile, and inhalation is 
the most common occupational exposure route, although exposure can also occur dermally 
or orally.1 Several organic solvents have been classified as probable reproductive hazards.2
Congenital heart defects (CHDs), with an overall birth prevalence of approximately 1%, are 
among the most common types of birth defects3,4 and are a leading cause of birth defects-
associated mortality, morbidity and costs.5–7 Reported associations between CHDs and 
occupational solvent exposures have been inconsistent. Studies using linked data between 
the Finnish Register of Congenital Malformation and the Children’s Cardiac Register 
(1982–1984) identified occupational exposure to organic solvents as a risk factor for CHD 
subtypes, including ventricular septal defects (VSDs) 8,9 and conotruncal defects (with 
exposure to “dyes, lacquers or paints”).10 Results from the Baltimore Washington Infant 
Study (BWIS; 1981–1989) indicated associations between organic solvents and all CHDs 
combined, as well as with left ventricular outflow tract (LVOT) obstruction defects 
(specifically, hypoplastic left heart syndrome and coarctation of the aorta), conotruncal 
defects (specifically, tetralogy of Fallot and transposition of the great arteries),11,12 
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pulmonary stenosis,11–13 total anomalous pulmonary venous return,14 and Ebstein’s 
malformation.15 Neither the Finnish registry studies nor the BWIS made use of industrial 
hygiene expertise to assess the potential for exposure to various solvents associated with 
jobs held by study participants during pregnancy and based their analyses entirely on 
maternally reported job titles and self-reports of occupational exposures. Other studies using 
similar exposure assessment methods relying exclusively on self-reported job titles and 
exposures have not suggested a role for maternal exposure to organic solvents in the 
etiology of CHDs.16,17
The National Birth Defects Prevention Study (NBDPS), an on-going, multisite, population-
based case control study exploring both genetic and non-genetic risk factors for birth 
defects–. As part of the study, industrial hygienists estimated maternal occupational 
exposures to organic solvents for study participants who delivered between 1997 and 2002. 
Funding for the occupational exposure assessment was limited, and therefore only 
completed for data from the first five study years. Given these exposure data and the 
detailed review and refined classification of all CHD cases in the study,18,19 the NBDPS 
dataset provides a unique opportunity to investigate the association between maternal 
occupational exposure to organic solvents and CHDs. Specifically, we investigated possible 
associations between 15 categories of CHDs and classes of organic solvents for which 
exposures are likely to occur in occupational settings: chlorinated solvents, aromatic 
solvents, and a mixture of C10 or higher hydrocarbons known as Stoddard solvent.
METHODS
Study Population
NBDPS cases were identified from eight birth defects surveillance systems throughout the 
United States (Arkansas, California, Georgia, Iowa, Massachusetts, New Jersey, New York, 
and Texas).20 Cases in the study had at least one of over 30 eligible birth defects and were 
live born, stillborn, or electively terminated. Control infants (live born infants without major 
birth defects) were randomly selected from birth certificates or birth hospital records from 
the same geographic populations that gave rise to the cases. The NBDPS annually enrolled 
all eligible cases and approximately 150 controls per study center. Mothers of cases and 
controls were interviewed by telephone in either English or Spanish using a computer-based 
questionnaire 6 weeks to 24 months after the estimated date of delivery. Interviewers 
obtained information on maternal demographic characteristics, exposures (e.g., nutritional, 
behavioral, occupational) and medication use both before and during pregnancy. The 
participation rate for mothers of control infants was 67% and for mothers of CHD cases was 
69%. The NBDPS was approved by the institutional review boards of Centers for Disease 
Control and Prevention (CDC) and the participating study centers.
Clinical review and classification of congenital heart defects
The systematic review of all NBDPS cases by clinical geneticists resulted in the exclusion of 
those with recognized or strongly suspected single-gene conditions or chromosome 
abnormalities. All CHD cases were confirmed by echocardiography, cardiac catheterization, 
surgery, or autopsy18,19 and their diagnostic information was reviewed by a team of 
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clinicians with expertise in pediatric cardiology and clinical genetics for classification on 
two axes. The first axis of classification focused on the heart itself. “Simple” cardiac defects 
were anatomically discrete or a well-recognized single entity (e.g., hypoplastic left heart 
syndrome or tetralogy of Fallot). “Associations” were common, uncomplicated 
combinations of (typically two) cardiac defects (e.g. ventricular septal defect and pulmonary 
valve stenosis). CHDs that included three or more distinct defects were considered 
“complex”.18 The second axis of classification considered whether the infant had defects 
outside the heart. Infants with no major extracardiac defects were classified as isolated CHD 
cases, while those with extracardiac defects were classified as multiple CHD cases.18,19 
Clinical reviewers also determined the specific CHD phenotypes of every case according to 
rigorous guidelines.18
Inclusion Criteria
Mothers of CHD case or control infants delivered on or after October 1, 1997 who had an 
estimated date of delivery on or before December 31, 2002 composed the initial study 
population (N=8,733). Those who worked in paid, volunteer or military service, including 
part-time and full-time jobs, jobs at home, jobs on a farm or jobs outside the home that 
lasted one month or more between the period of three months before conception through the 
end of the index pregnancy were eligible for these analyses (N=6,333[N=2,997 control 
mothers; N=3,344 case mothers]). We excluded those with a first degree family history of 
CHD (N=31 control mothers; N=121 CHD case mothers) and mothers with pregestational 
diabetes (N=15 control mothers; N=102 CHD case mothers), as these are strong risk factors 
for CHDs. Additionally, mothers of CHD cases with extracardiac defects (N=520) or cases 
with associated or complex CHDs (N=554) were excluded. The final study population 
included 2,951 mothers of controls and 2,047 mothers of simple, isolated CHD cases. We 
analyzed CHD cases in the aggregate (“any CHD”) and by specific subtype with at least 50 
cases. The total group of “any CHD” includes all subtypes that are reported individually, as 
well as subtypes with fewer than 50 simple, isolated cases representing diagnostic groups 
that were too sparse to be analyzed individually.
During the study period, there were a few changes in the eligibility of specific CHDs as well 
as changes in state protocols for ascertainment. Simple, isolated muscular VSDs were only 
included in the NBDPS during the first year of data collection.21 In addition, California 
began ascertaining cases with pulmonary valve stenosis according to NBDPS criteria for 
births on or after January 1, 2002. Control samples for these specific CHDs were 
accordingly restricted by ascertainment dates and study center.
Exposure Assessment
Each mother was asked to report whether she worked in a full- or part-time job for at least 
one month in duration, from three months before conception through the end of pregnancy. 
If she did report working, she was asked a series of questions about each job she held, 
including the job title, main tasks and duties, and any chemicals or substances to which she 
thought she was exposed or machines she used while working. Beginning and ending dates 
for each job were collected, as well as the hours per day and days per week worked (Online 
Appendix 1). Each job was coded for occupation and industry using the Standard 
Gilboa et al. Page 4













Occupational Classification System (SOC) and the North American Industry Classification 
System (NAICS).22,23 Two independent exposure assessment strategies were then 
conducted by a team of industrial hygienists and occupational epidemiologists: an expert 
consensus-based approach24–26 and a literature-based approach.27–29
The expert consensus-based approach involved the independent classification of exposure 
by two industrial hygienists, blinded to case status. 25,26 After reviewing all self-reported 
information from the questionnaire, the hygienists rated each maternal job as potentially 
exposed to any of six chlorinated solvent (defined as carbon tetrachloride, chloroform, 
methylene chloride, perchloroethylene, 1,1,1-trichloroethane, or tricholoroethylene) and/or 
Stoddard solvent; exposure to aromatic solvents was not estimated using this approach. 
Discrepancies in exposure assignment between the two hygienists were resolved by majority 
consensus among the original two hygienists and a third.
For the literature-based approach, agent- and era- (1997–1999, 2000–2002) specific job-
exposure matrices were developed after a comprehensive review of the published literature, 
including measurement data abstracted from industry technical reports and industrial 
hygiene contextual information. Additional details have been described in the literature.27–30 
The job-exposure matrices were used in combination with an expert industrial hygiene 
review of the self-reported job information from the questionnaire to classify each maternal 
job as exposed or unexposed to each of three aromatic solvents (benzene, toluene, xylene), 
six chlorinated solvents (carbon tetrachloride, chloroform, methylene chloride, 
perchloroethylene, 1,1,1-trichloroethane, and trichloroethylene) and Stoddard solvent. Each 
maternal job’s probability of exposure to each solvent was rated as 0, 1–9%, 10–49%, 50–
89%, and ≥90% by the industrial hygienists.
In both approaches, exposure was defined as that which occurred for any duration from one 
month before conception through the end of the first trimester – a time period which 
includes the most relevant windows for cardiac development.31 For each exposure 
assessment method, for each class of solvent or Stoddard solvent, a mother was considered 
exposed if she reported having one or more jobs at any point during this time period that 
were rated as exposed by that method. She was considered unexposed if all her jobs during 
this time period were rated as unexposed to all of the evaluated solvents by that method, or 
if she was employed exclusively outside of the periconceptional time period (e.g., employed 
only in the 3rd trimester).
Exposure and Covariate Definitions
Using exposure data from the expert consensus-based approach, we analyzed exposure to (1) 
any solvent (i.e., any chlorinated solvent or Stoddard solvent); (2) any chlorinated solvent; 
and (3) Stoddard solvent. Although exposure data for individual solvents were available 
from the literature-based approach, we ultimately analyzed exposure to (1) any solvent (i.e., 
any chlorinated or aromatic solvent, or Stoddard solvent); (2) any aromatic solvent; (3) any 
chlorinated solvent; and (4) Stoddard solvent, to facilitate comparison of results across 
approaches and because of methodological issues discussed below, including exposure 
correlation within solvent class. Because we had no a priori reason to favor the results from 
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one exposure assessment approach over another, we present results based on both 
approaches.
Three maternal demographic characteristics that have been associated with CHDs as a group 
and/or with specific CHD lesions and are likely to be associated with occupational 
exposures were identified a priori as potential confounders: maternal age (<20, 20–24, 25–
29, 30–34, and ≥35 years), maternal race and ethnicity (non-Hispanic White, non-Hispanic 
Black or African American, Hispanic, and other race), and maternal education (less than 
high school, completion of high school, and more than high school). Two additional 
potential confounders were considered: maternal smoking, associated with increased risk for 
some CHD phenotypes,32,33 and folic acid supplement intake, associated with a decreased 
risk for some CHD phenotypes.34 Both were categorized dichotomously (any/none) based 
on use during the month before pregnancy or any time during the first trimester.
Statistical Analysis
Exploratory data analysis included the calculation of frequency distributions of the selected 
covariates and solvent exposures among mothers of CHD cases and controls. Chi-square 
tests of association were used to assess the statistical significance of differences in these 
frequency distributions. We also assessed the overlap in exposures within each exposure 
assessment method. Solvent-class-specific multiple logistic regression models, including the 
five a priori covariates noted above, were used to estimate adjusted odds ratios (ORs) and 
95% confidence intervals (CI) for CHD subtypes with more than one exposed case. Finally, 
we conducted a sensitivity analysis of the literature-based approach using the estimates of 
probability of exposure for each solvent. For each solvent class, we assessed the impact of 
restricting the exposure to mothers with jobs in which the probability of exposure was 
greater than or equal to 50%.
RESULTS
Exploratory analyses
Considering mothers of all CHD cases combined compared with mothers of controls, there 
were no significant differences with respect to the prevalence of exposure, or the socio-
demographic and behavioral characteristics considered (Table 1). However, the two 
exposure assignment approaches yielded different prevalences of exposure. Using the expert 
consensus-based approach, approximately 4% of controls and 5% of cases were exposed to 
any solvent during the periconceptional period; using the literature-based approach, 
approximately 8% of controls and 10% of cases were exposed to any solvent.
Among control mothers rated as exposed using the expert consensus-based approach 
(N=110), 66% were considered exposed to only chlorinated solvents, 8% to only Stoddard 
solvent, and 26% to both chlorinated solvents and Stoddard solvent (Table 2). Among 
control mothers rated as exposed using the literature-based approach (N=240), 50% were 
considered exposed to only chlorinated solvents, 9% to only aromatic solvents, and 6% to 
only Stoddard solvent. The remaining 85 mothers (35%) were rated as exposed to at least 
two classes of solvents. There was also substantial overlap of exposure to specific solvents 
Gilboa et al. Page 6













within solvent classes in the literature-based approach (i.e. among the 61 controls exposed to 
aromatic solvents only 3% were exposed to only one solvent, and among the 203 controls 
exposed to chlorinated solvents only 13% were exposed to only one solvent).
Expert Consensus-Based Approach
Two borderline statistically significant associations between occupational exposure to 
classes of organic solvents and simple, isolated CHDs were observed when using the expert 
consensus-based approach: any solvent and chlorinated solvents were both associated with 
perimembranous VSDs (any solvent: OR 1.6; 95% CI 1.0 to 2.6; chlorinated solvents: OR 
1.7; 95% CI 1.0 to 2.8) (Table 3).
Literature-Based Approach
Several borderline and statistically significant associations between occupational exposure 
to classes of organic solvents and simple, isolated CHDs were observed when using the 
literature-based approach: any solvent with aortic stenosis (OR 2.1; 95% CI 1.1 to 4.1); and 
Stoddard solvent with d-transposition of the great arteries (OR 2.0; 95% CI 1.0 to 4.2), right 
ventricular outflow tract (RVOT) obstruction defects (OR 1.9; 95% CI 1.1 to 3.3) and 
pulmonary valve stenosis (a subtype of RVOT obstruction defects) (OR 2.1; 95% CI 1.1 to 
3.8) (Table 4). After restricting exposed mothers to those with at least one job rated as 
exposed with a 50% or greater probability, (81/194 [42%] cases; 80/240 [33%] controls), we 
observed several additional associations: any solvent exposure with any CHD (OR 1.4; 95% 
CI 1.0 to 1.9) and septal defects (OR 1.5; 95% CI 1.0 to 2.3); and Stoddard solvent exposure 
with any CHD (OR 2.8; 95% CI 1.3 to 6.2), septal defects (OR 3.1; 95% CI 1.2 to 8.0), 
perimembranous VSD (OR 3.7; 95% CI 1.1 to 12.2), and atrial septal defects (OR 3.8; 95% 
CI 1.2 to 12.6). Perimembranous VSD and atrial septal defects are both subtypes of septal 
defects. The originally observed associations of any solvent exposure with aortic stenosis 
and Stoddard solvent with d-transposition of the great arteries were not estimated because 
there was only one exposed case of each CHD. The originally observed associations of 
Stoddard solvent with RVOT obstruction defects and pulmonary valve stenosis 
strengthened, but lost precision (OR 4.6; 95% CI 1.4 to 15.3 and OR 4.2; 95% CI 1.1 to 
16.2, respectively) (Online Appendix 2).
DISCUSSION
Overall, our results indicate that maternal occupational exposure to organic solvents during 
the period of one month before conception through the first trimester of pregnancy is a 
potential risk factor for some specific CHD phenotypes. The observed associations with 
individual CHDs may warrant further investigation, given that some of these associations 
have been previously reported in the literature. We observed associations with specific 
subtypes of LVOT obstruction defects, RVOT obstruction defects, conotruncal defects, and 
septal defects. Associations between solvents and LVOT obstruction defects were 
previously observed in the BWIS – specifically, with “degreasing agents” (which may 
include the solvents analyzed in the current study as well as others not analyzed here). 
BWIS data also showed an association with hypoplastic left heart syndrome, an LVOT 
obstruction defect subtype, for which we did not see any associations in our data. In 
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addition, BWIS data showed an association between a high cumulative solvent level and a 
different LVOT obstruction defect subtype, coarctation of the aorta.11,12 Our results for 
Stoddard solvent and RVOT obstruction defects, specifically pulmonary valve stenosis, are 
consistent with findings from the BWIS, which also reported an association between 
pulmonary valve stenosis and “degreasing agents”.11 Our results for perimembranous VSD 
were previously suggested by Finnish data (though their results were reported for VSDs in 
the aggregate, not by VSD subtype)8, but not in data from the BWIS.
With respect to the similarity of associations across exposure assessment methods, arguably 
septal defects and RVOT obstruction defects were more consistently associated with 
solvents than LVOT obstruction defects or conotruncal defects. Given that the previous 
literature has reported associations across several subtypes, these results add to the literature 
suggesting that associations are present, but do not clarify which of these associations are 
more likely to be causal.
The exact biological mechanism whereby exposure to organic solvents during the 
periconceptional period could result in CHDs is unknown. One potential mechanism of 
interest is oxidative stress.35 Several chlorinated solvents are known to cause oxidative 
stress in animal models. Additionally, there is evidence from animal models that maternal 
exposure to chlorinated solvents is associated with CHDs. For instance, toxicologic studies 
using both chick embryos and fetal rats have shown an increased risk for CHDs in animals 
exposed to the chlorinated solvent tricholoroethylene and its metabolites. No particular CHD 
subtypes have predominated - septal defects, as well as left-sided and right-sided obstructive 
defects have been reported.36,37
The potential for exposure misclassification in one or both exposure assessment strategies is 
the most important potential limitation of the current study.38
A recent analysis of the NBDPS expert consensus data found that inter-rater reliability of 
exposure status (yes/no) improved substantially when discordant ratings were resolved via 
consensus conference. Kappa coefficients increased from 0.59 to 0.81 for chlorinated 
solvents, and from 0.55 to 0.92 for Stoddard solvent when comparing estimates developed 
before the conference with a set of estimates developed after the conference on different 
jobs.24 Exposure misclassification was therefore reduced to some degree by using the 
consensus assessments as the final estimated exposure status; however, some inaccuracy in 
true exposure assignment likely remains, resulting in the potential for residual exposure 
misclassification.
Both the consensus-based and the literature-based approach were subject to exposure 
misclassification due to the correlation of exposures within a solvent class. There was 
generally insufficient detail available from the maternal questionnaire responses for the 
industrial hygienists to identify specific chlorinated solvents, singly or in combination, to 
which the mother was exposed during her job, especially because several chlorinated 
solvents may be used interchangeably in some tasks and jobs, such as degreasing. This 
overlap would have made the interpretation of associations with individual solvents 
challenging and therefore, the decision was made to conduct an analysis based on solvent 
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classes instead. Although this decision mitigated the problem of interpreting individual 
solvent results, it may have resulted in a dilution of any true associations with individual 
solvents, as was likely the situation in the expert consensus-based approach as well. In 
addition, both exposure assessment methods were indirect and retrospective, and yielded 
estimates of exposure with unknown sensitivity and specificity compared to true exposure 
status. Since there was no gold standard against which the exposure assessments could be 
compared, nor was there a biological marker to use for validation, it was not possible to 
determine the accuracy of one assessment method over another.
We expected that exposure misclassification in this study would dilute the dichotomous 
(yes/no during the periconceptional period) exposure contrast and, assuming there is an 
underlying positive association between maternal exposure to organic solvent(s) and one or 
more CHDs, the observed effect estimates would be biased toward the null. Our sensitivity 
analysis of the literature-based method was intended to sharpen the exposure contrast by 
limiting exposed jobs to those with estimated probability of exposure ≥50%. In this 
secondary analysis, two of the originally observed relationships were strengthened in 
magnitude (i.e. Stoddard solvent and RVOT obstruction defects and pulmonary valve 
stenosis), though the loss in sample size reduced precision. Several previously unseen 
associations were noted (e.g. Stoddard solvent and septal defects, and atrial septal defects), 
which may have been unobserved in the primary analysis due to exposure misclassification.
Several additional study limitations should be noted. First, our decision to only consider a 
dichotomization of exposure limited our ability to explore an exposure-response 
relationship, which is one criterion of causality. Although information was available on the 
metrics that could allow such an investigation (intensity and frequency of exposure), our 
limited sample size of exposed mothers within each CHD subtype restricted our ability to 
further classify them by these metrics. In addition, there was insufficient variation in these 
other metrics to adequately conduct a CHD-subtype-specific exposure-response analysis.
Second, we were unable to account for potential exposures to solvents outside of the work 
environment, such as through painting or cleaning/degreasing activities at home or as part of 
hobbies. Some solvents, such as trichloroethylene and its metabolites, are known drinking 
water contaminants in the United States; our study did not assess solvent exposure via 
drinking water.39 The extent to which these additional sources of solvent exposure might 
have resulted in appreciable misclassification depends on whether such exposures occurred 
with comparable frequency and intensity during the period of interest. Unfortunately, we 
had no data to assess the extent to which non-occupational exposures contributed to the total 
exposure burden.
Third, biased or inaccurate recall are possibilities for at least two reasons – first, because of 
the time delay from delivery to interview (in our data, approximately 11 months for mothers 
of CHD cases and 9 months for mothers of controls), and second, because mothers of CHD 
cases could be more concerned than mothers of controls about their on-the-job exposures 
and be more likely to report exposure to substances that they perceived as hazardous. 
However, in our data, there were no differences in the rating of solvent exposure (using 
either method) by the time between delivery and interview (not shown). In addition, because 
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the foundation of the occupational exposure assessment was the maternal report of job title 
and tasks (rather than specifics of her potential on-the-job solvent exposures) we think it is 
relatively unlikely that these data were affected by biased recall. In theory, however, if 
mothers of CHD cases reported a more complete occupational history, they would have a 
greater probability of an accurate assignment of exposure. In our data, mothers of CHD 
cases and controls had a very similar distribution of the total number of jobs held (not 
shown), suggesting that a differential recall of occupational history did not occur.
Fourth, selection bias could be a possibility if participation in the study were influenced by 
both exposure and outcome status. Participation in the NBDPS is, by design, influenced by 
outcome status; it is unlikely to be influenced by exposure status. As discussed above, 
clinical reviewers with expertise in pediatric cardiology review every CHD case to 
determine whether the case meets the criteria for inclusion in the study. This process of 
clinical review is undertaken without regard for the nature of the interview data collected 
(e.g. completion of the questionnaire, specific responses to questions of exposure). With 
respect to NBDPS controls, they have been found to generally represent their base 
populations with respect to several maternal and paternal demographic factors.40 As stated 
above, the participation rate was 69% among mothers of CHD cases and 67% among 
mothers of controls, and these analyses were limited to mothers who reported working for at 
least one month in duration, at some point from three months before pregnancy through the 
end of pregnancy. Mothers who noted no employment during this time period were not 
assessed for occupational exposures – and were therefore excluded from this analysis.
Fifth, we conducted a large number of analyses (n=105; 15 CHD categories * 7 exposure 
variables in the two exposure assessment approaches combined) and, given a 0.05 
probability of a false positive result, all of our findings could be due to chance alone. And 
finally, although approximately 90% of CHDs are detected prenatally or before the infant 
reaches one year of age41 and the NBDPS relies on high quality birth defects surveillance 
systems to ascertain cases, CHDs that manifest later in childhood or in adulthood are not 
included in the NBDPS. Therefore, this analysis does not reflect potential associations with 
these late-diagnosed CHDs.
One strength of our study was that both the expert consensus-based approach and the 
literature-based approach were expected to provide more accurate exposure ratings than 
would have been available through a strategy that relied solely on maternal self-reports. The 
NBDPS questions asking about solvent exposure (Online Appendix, Question 12e) were 
relatively insensitive for ascertaining exposure; if we had relied solely on these maternal 
reports, our results would have been quite different. For example, as reported in the Results, 
the literature-based approach identified 61 control mothers as potentially exposed to 
aromatic solvents. Only 10 out of these 61 mothers affirmatively answered the question 
about solvent exposure in the NBDPS questionnaire; three of the 10 responses were a 
specified aromatic solvent (two reported toluene and one reported xylene exposure) (data 
not shown).
A second strength is the large number of CHD cases available for study, all of which were 
carefully reviewed by clinical geneticists and clinicians with expertise in pediatric 
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cardiology to ensure that case inclusion criteria were met and that the cases were accurately 
classified for analysis. The inclusion of only simple, isolated CHDs ensured that we had the 
most homogeneous case groupings possible and therefore we likely substantially reduced the 
possibility of outcome misclassification.
Finally this study provides results with a greater level of detail than those currently available 
in the literature, by reporting associations between specific solvent classes and CHD 
subtypes.
CONCLUSION
We observed associations between occupational exposure to solvents and several types of 
simple, isolated CHDs. Some of these findings were consistent with those previously 
reported in the literature, and other findings were new, yet all warrant corroboration in other 
study populations. Despite the strengths of this analysis, the results do not allow for the 
drawing of definitive conclusions on specific exposure-CHD combinations. These results 
should be interpreted with caution in light of the potential for misclassification in both 
exposure assessment methods.
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What This Paper Adds
Previous studies have suggested an association between several subtypes of congenital 
heart defects (CHDs) and occupational exposure to organic solvents. The results from 
this large, population-based, case-control study corroborate some earlier findings, and 
suggest additional associations for consideration. Because CHDs were categorized based 
on detailed clinical review, and exposure to aromatic and chlorinated solvents was 
determined by industrial hygienist review, the results reported in this study are the most 
specific with respect to both solvent and CHD type that are currently available in the 
literature.
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